Figure - available from: Vaccines
This content is subject to copyright.
Attitudes of participants towards COVID-19 vaccine. (A) Do not rely on the COVID-19 vaccine due to emergency developments during the pandemic. (B) Vaccination is not required because immunity will be acquired naturally by infection. (C) The newly discovered COVID-19 vaccine is safe. (D) It is not possible to reduce the incidence of COVID-19 without vaccination. (E) COVID-19 Vaccines are safe, and I will take the COVID-19 vaccine without any hesitation.

Attitudes of participants towards COVID-19 vaccine. (A) Do not rely on the COVID-19 vaccine due to emergency developments during the pandemic. (B) Vaccination is not required because immunity will be acquired naturally by infection. (C) The newly discovered COVID-19 vaccine is safe. (D) It is not possible to reduce the incidence of COVID-19 without vaccination. (E) COVID-19 Vaccines are safe, and I will take the COVID-19 vaccine without any hesitation.

Source publication
Article
Full-text available
Vaccination is one of the essential measures in reducing transmission, morbidity, and mortality rates of a disease. However, the COVID-19 vaccination is facing hesitancy across the globe, Malawi included. A population-based cross-sectional study was conducted in Malawi to document knowledge, attitudes, and practices on COVID-19 vaccination. The stu...

Citations

... Therefore, numerous variables influence the degree of uptake of COVID-19 vaccines such as demographical factors of age, sex, and geographic location [14]. Socio-economic status such as income level and employment [12]. Besides, educational attainment and awareness campaigns are effective in public health [20]. ...
Article
Full-text available
Background Despite the advantages of vaccination in preventing maternal and fetal problems, there were many concerns in the medical community regarding vaccine safety for pregnant women, and this has put obstetricians in a challenging situation when it comes to advising their pregnant patients on whether to obtain the vaccine Aim This study was performed to define the level of acceptance of COVID-19 vaccination and assess the impact of COVID-19 attitudes and knowledge on vaccine acceptance between pregnant and lactating Syrian women who are seeking prenatal care services at the clinics in Azraq refugee camp in Jordan. Method A quantitative, cross-sectional study utilizing a non-probability convenience sample. A validated and reliable self-administered questionnaire consisting of four sections was used. Results A total of 412 pregnant/lactating women was recruited The acceptance rate of the COVID-19 vaccine among participants was 86.5%. There was a significant positive moderate association between respondents’ attitudes and knowledge around the COVID-19 vaccine and their acceptance of the vaccine (r = .468, p < .001, r = .357, p < .001), respectively. Conclusion To effectively mitigate the COVID-19 pandemic and achieve collective protection, decision-makers must intensify the efforts in promoting the importance of maternal vaccination, especially in vulnerable communities that suffer the most from pandemic outcomes.
Article
Full-text available
As the fight against the COVID-19 pandemic continues, reports indicate that the global vaccination rate is still far below the target. Understanding the levels of reinfection may help refocus and inform policymakers on vaccination. This retrospective study in Malawi included individuals and patients who tested for COVID-19 infections via reverse transcriptase polymerase chain reaction (rt-PCR) from the data at the Public Health Institute of Malawi (PHIM). We included all data in the national line list from April 2020 to March 2022. Upon review of 47,032 records, 45,486 were included with a reported 82 (0.18) reinfection representing a rate of 0.55 (95% CI: 0.44-0.68) per 100,000 person-days of follow-up. Most reinfections occurred in the first 90 to 200 days following the initial infection, and the median time to reinfection was 175 days (IQR: 150-314), with a range of 90-563 days. The risk of reinfection was highest in the immediate 3 to 6 months following the initial infection and declined substantially after that, and age demonstrated a significant association with reinfection. Estimating the burden of SARS-CoV-2 reinfections, a specific endurance of the immunity naturally gained, and the role played by risk factors in reinfections is relevant for identifying strategies to prioritise vaccination.